Trial Site Detail
Drug: |
Lenvatinib |
|||
|---|---|---|---|---|
Trial: |
Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure (LENVAGIST) |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Recruiting |
|||
Institut Paoli Calmette |
Principal Investigator: |
François Bertucci |
|---|---|
Contact: |
François Bertucci, Pr bertuccif@ipc.unicancer.fr |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
Institut Paoli Calmette Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.